Xolair (omalizumab)

pCPA File Number: 20897
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Idiopathic Urticaria
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0398-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: